MetLife Investment Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,037
| Closed | -$91.4K | – | 2909 |
|
|
2024
Q1 | $91.4K | Buy |
+4,037
| New | +$91.4K | ﹤0.01% | 2577 |
|
|
2023
Q4 | – | Sell |
-4,016
| Closed | -$80.7K | – | 2848 |
|
|
2023
Q3 | $80.7K | Hold |
4,016
| – | – | ﹤0.01% | 2691 |
|
|
2023
Q2 | $108K | Buy |
4,016
+1,264
| +46% | +$33.9K | ﹤0.01% | 2629 |
|
|
2023
Q1 | $161K | Buy |
2,752
+792
| +40% | +$46.2K | ﹤0.01% | 2350 |
|
|
2022
Q4 | $99.9K | Sell |
1,960
-801
| -29% | -$40.8K | ﹤0.01% | 2593 |
|
|
2022
Q3 | $226K | Buy |
2,761
+1,213
| +78% | +$99.3K | ﹤0.01% | 2215 |
|
|
2022
Q2 | $105K | Sell |
1,548
-1,237
| -44% | -$83.7K | ﹤0.01% | 2694 |
|
|
2022
Q1 | $308K | Buy |
2,785
+985
| +55% | +$109K | ﹤0.01% | 2077 |
|
|
2021
Q4 | $174K | Buy |
1,800
+1,163
| +183% | +$112K | ﹤0.01% | 2142 |
|
|
2021
Q3 | $55.6K | Sell |
637
-944
| -60% | -$82.4K | ﹤0.01% | 2523 |
|
|
2021
Q2 | $245K | Hold |
1,581
| – | – | ﹤0.01% | 2027 |
|
|
2021
Q1 | $249K | Sell |
1,581
-518
| -25% | -$81.7K | ﹤0.01% | 1933 |
|
|
2020
Q4 | $487K | Hold |
2,099
| – | – | ﹤0.01% | 1509 |
|
|
2020
Q3 | $460K | Hold |
2,099
| – | – | 0.01% | 1407 |
|
|
2020
Q2 | $596K | Buy |
2,099
+383
| +22% | +$109K | 0.01% | 1286 |
|
|
2020
Q1 | $495K | Sell |
1,716
-248
| -13% | -$71.5K | 0.01% | 1222 |
|
|
2019
Q4 | $565K | Hold |
1,964
| – | – | 0.01% | 1393 |
|
|
2019
Q3 | $283K | Hold |
1,964
| – | – | ﹤0.01% | 1738 |
|
|
2019
Q2 | $176K | Buy |
+1,964
| New | +$176K | ﹤0.01% | 2104 |
|
|
2019
Q1 | – | Sell |
-1,536
| Closed | -$216K | – | 2583 |
|
|
2018
Q4 | $216K | Hold |
1,536
| – | – | ﹤0.01% | 1865 |
|
|
2018
Q3 | $392K | Hold |
1,536
| – | – | ﹤0.01% | 1690 |
|
|
2018
Q2 | $392K | Buy |
1,536
+519
| +51% | +$132K | ﹤0.01% | 1554 |
|
|
2018
Q1 | $205K | Hold |
1,017
| – | – | ﹤0.01% | 1877 |
|
|
2017
Q4 | $146K | Buy |
+1,017
| New | +$146K | ﹤0.01% | 2080 |
|